Advanced Chart Created with Highcharts 8.2.2© quotemedia Earnings
Last month, America’s Bloomberg news agency reported on a German demand that proposed measures do not include restrictions on energy, insisting that the sector be exempted. Read more … Happens every year. Just a bit louder this time. • NY Times, Washington Post Driving US to War with ...
AstraZenecais now expecting total revenue excluding Covid drugs to increase by a low-teens percentage, up from a previously guided low double-digit rise. Core earnings per share are forecast to rise by as much as a high double-digit percentage, up from a best-case scenario of a low double...
AstraZeneca contacted Gilead last month, but its U.S. rival was not interested in combining with another big pharmaceuticals company, the Bloombergreportsaid. A spokeswoman for AstraZeneca said the company does not comment on rumours or speculation. Gilead, the world's largest maker of HIV drugs...
(viii) Unless otherwise stated all prices and closing prices for Alexion Shares and AstraZeneca Shares are derived from Bloomberg. (ix) The volume weighted average price of an Alexion Share is derived from Bloomberg by reference to the volume weighted average price over the last 30 Alexion trad...
ViacomCBS shaken up on the stock market after a $3bn share offering. Grupo Televisa and Univision are reportedly discussing a merger, according to Bloomberg. Fitch sees risks for Credit Suisse due to the Greensill deal. Citigroup did business with Greensill before its collapse, despite advers...
“I read and hear and see lots of things, but we’re here trying to change policy, make good decisions and execute our strategy,” the CEO told Bloomberg, vowing to stick to the game plan. “Maybe somebody sees something different, but spending more money does not have a linear increase...
Glaxo's consumer business could go for as much as 40 billion pounds ($54 billion), knowledgeable sources tell Bloomberg. GSKKKRCG Investing News, Analysis, and Tips Oct 8, 2021 12:04 PM EDT COVID Update: Vaccine Booster Shots, Alternate Treatments Wrap Up A quick summary of the latest in...